Confidentiality and Data Privacy. The Investing Fiduciary and State Street expressly undertake to maintain the confidentiality of: (i) the portfolio holdings of each Fund, as well as any index license fees, (ii) personal information processed in connection with this Agreement, which may include personally identifiable information subject to applicable privacy or data protection laws, and (iii) the parties’ activities hereunder that are either designated as being confidential, or that, by the nature of the circumstances surrounding the disclosure, ought in good faith be treated as proprietary or confidential (collectively the “Confidential Information”); provided, however, that Confidential Information shall not include, if the Qualified Investor is a multiemployer plan (as defined in ERISA) subject to ERISA, any quarterly, semi-annual, or annual financial report (as determined under Section 101(k) of ERISA) prepared for the Qualified Investor by State Street if all or any portion of such financial report is not marked or identified as “Proprietary Information”. If the Investing Fiduciary or State Street is subject to disclosure obligations under the U.S. Freedom of Information Act or other applicable disclosure statute or regulation, either party may disclose the Confidential Information pursuant to the requirements of such law or regulation. The Investing Fiduciary or State Street shall put in place appropriate security measures to prevent the Confidential Information from being accidentally lost, used, altered, disclosed or accessed in an unauthorized way. Neither the Investing Fiduciary nor State Street shall disclose Confidential Information except: (i) to its employees, consultants, legal advisors, affiliates, third party service providers or auditors, which may be located outside of the United States, who have a need to know such Confidential Information; (ii) in accordance with a judicial or other governmental order or when such disclosure is required by law, provided that prior to such disclosure, the party in receipt of Confidential Information of the other party (the “Receiving Party”) shall, so long as permitted by applicable law and regulation, provide the other party (the “Disclosing Party”) with written notice and shall comply with any protective order or equivalent; or (iii) in accordance with an audit or inquiry by a regulatory or self-regulatory agency, without prior notice to the Disclosing Party, provided that the Receiving Party shall obtain a confidentiality undertakin...
Confidentiality and Data Privacy. Unless otherwise stated in writing, the Parties acknowledge that these GTC and any oral or written information exchanged between the Parties in connection with Supplier’s Services and any related business are regarded as confidential information. Customer shall maintain confidentiality of all such confidential information, and without obtaining the prior written consent of the Supplier Customer shall not disclose any relevant confidential information to any third party, except for the information that: (a) is or will be in the public domain (other than through the receiving Customer’s unauthorized disclosure); (b) is under the obligation to be disclosed pursuant to the applicable laws or regulations, or orders of the court or other government authorities; or (c) is required to be disclosed by Customer to its shareholders, investors, legal counsels or financial advisors regarding the transaction contemplated hereunder, provided that such shareholders, investors, legal counsels or financial advisors shall be bound by the confidentiality obligations similar to those set forth in this clause 9. Disclosure of any confidential information by the staff members or agencies hired by Customer shall be deemed disclosure of such confidential information by such the Customer, in which Customer shall be held liable for breach of these GTC. This clause shall survive the termination of these GTC for any reason.
Confidentiality and Data Privacy. 8.1 For the avoidance of doubt: (a) any information disclosed by one Party to the other Party pursuant to this Agreement (including through any audit or inspection conducted pursuant to this Agreement or during any meeting of the Joint Project Team, Joint Steering Committee, Joint Manufacturing Committee or the Joint Financial Committee) shall constitute information related to the subject matter of the License Agreement for the purposes of the definition of “Confidential Information” under the License Agreement, and the provisions in such definition and Section 8 of the License Agreement shall apply to such information accordingly; and (b) the Sanofi Co-Development Technology, Co-Development Background Technology of Sanofi, Regulatory Documentation filed by Sanofi or its Affiliate and Clinical Data shall constitute Sanofi’s Confidential Information (in respect of which Sanofi is the Disclosing Party and Biontech the Receiving Party) and the Biontech Co-Development Technology, CMC Technology and Co-Development Background Technology of Biontech shall constitute Biontech’s Confidential Information (in respect of which Biontech is the Disclosing Party and Sanofi the Receiving Party).
Confidentiality and Data Privacy. Gaia Insights and its business partners undertake to treat as confidential any operating and business secrets, as well as sensitive participant data, Human Resources information and any other matters concerning the Client with which Gaia Insights and its business partners are entrusted or become familiar in the course of providing Services. In particular, Gaia Insights and its business partners undertake:
Confidentiality and Data Privacy. 8.1. We hold and process your personal information, including information on your health and any other information that will assist a Licensed Treatment Centre with your medical care (‘Special Category Data’) in accordance with our Privacy Notice, which you can view here: xxxxx://xxx.xxxxxx.xx.xx/privacy.
Confidentiality and Data Privacy. Section 1. The Parties are bound by strict non-disclosure of Confidential Information to third parties. The Parties guarantee that they shall comply with the physical, technical, and institutional protection of Confidential Information following the Data Privacy Act of 2012 (DPA) provisions.
Confidentiality and Data Privacy. NovImmune affirms the patient's right to protection against invasion of privacy and to be in compliance with ICH and other local regulations (whichever is more stringent). NovImmune requires the Investigator to permit NovImmune representatives and when necessary, representatives from regulatory authorities, to review and/or copy any medical records relevant to the study in accordance with local laws (any copies of patients’ records must be duly anonymised to protect patients’ confidentiality). Should direct access to medical records require a waiver or authorisation separate from the patient’s statement of informed consent, it is the responsibility of the Investigator to obtain such permission in writing from the appropriate individual.
Confidentiality and Data Privacy. 4.1. All information provided by the Client to the Therapist during a Consultation will be considered confidential. The Provider will not be entitled to disclose such information to third parties without the express consent of the Client, except as may be required for compliance with the obligations of the Therapist with applicable laws and regulations. The Client hereby consents and permits the Therapist (but the Therapist is not required) to disclose, as part of providing quality services, the content of the Consultations when conferring with other professional staff members of the Provider.
Confidentiality and Data Privacy. 13.1. All information and documents concerning the conduct of business pursuant to these general terms and conditions, including information relating to business methods, procedures, policies and sales information, is strictly confidential unless it is already in the public domain.
Confidentiality and Data Privacy. 4.1. Both Parties shall use all commercially reasonable steps to ensure that any Confidential Information shall not be disclosed to third parties without the prior written consent of the other Party.
